Qsymia Webpage’s ‘3 Times Faster’ Weight-Loss Claims Draw US FDA Ire

Claims that Vivus' obesity drug helps patients lose weight faster than diet and exercise alone are false and misleading because the clinical studies were not designed to evaluate the rate of weight loss over time, Office of Prescription Drug Promotion says in untitled letter; Vivus says it is finalizing revisions to its promotions.

obesity
US FDA says Vivus' claims about the rate of weight loss with Qsymia don't measure up. • Source: Shutterstock

More from Marketing & Advertising

More from Compliance